Dr. Kalaycio is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland, OH 44195Phone(800) 223-2273
- Is this information wrong?
Education & Training
Cleveland Clinic FoundationFellowship, Hematology, 1992 - 1994- Cleveland Clinic FoundationFellowship, Medical Oncology, 1991 - 1992
University of Pittsburgh Medical Center-Mercy HospitalResidency, Internal Medicine, 1988 - 1991
West Virginia University School of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2016 - 2018
MI State Medical License 2002 - 2021
NY State Medical License 2002 - 2022
IL State Medical License 2002 - 2020
CA State Medical License 2002 - 2020
CT State Medical License 2002 - 2006
PA State Medical License 1990 - 2021- American Board of Internal Medicine Hematology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Clinical Trials
- A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients Start of enrollment: 2012 Feb 01Emmanuel Katsanis, MD, Edward Ball, MD, Michael Lill, MD, Eric J Anderson, MD, Ralph Quinones, MD, Jonathan Gutman, MD, Michael Joyce, MD, Paul Gordon, MD, Aleksandra Petrovic, MD, Scott R Solomon, MD, Co...
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications Start of enrollment: 2011 Oct 01Abdel-Mageed, A.,Adams, R.,Agura, E.,Akard, L.,Al-Homsi, A.S.,Anderson, E.,Andreansky, M.,Andrey, J.W.,Aquino, V.,Avigan, D.,Bachier, C.,Ball, E.,Ballen, K.,Barker, J.,Bayer, R.L.,Berryman, R.B.,Bhatia, M...
- Phase II Study of Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy Start of enrollment: 2011 Jul 01Altman, J.,Jurcic, J.,Kalaycio, M.,Pullarkat, V.,Roboz, G.,Schuh, A.,Tallman, M.,Young, N.
- S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment Start of enrollment: 2009 Sep 01Kalaycio, M.E.
- Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2008 Nov 01Kalaycio, M.,Caimi, P.
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2001 Jun 01Kalaycio, M.E.
Publications & Presentations
PubMed
- DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone ...Jack Khouri, Beth Faiman, Dale Grabowski, Reda Z. Mahfouz, Shahper N. Khan, Wei Wei, Jason Valent, Robert M. Dean, Christy Samaras, Babal K. Jha, Hillard M. Lazarus, E...> ;Seminars in Hematology. 2021 Jan 1
- Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.Sanghee Hong, Lisa Rybicki, Donna Corrigan, Betty K. Hamilton, Ronald Sobecks, Matt Kalaycio, Aaron T. Gerds, Robert M. Dean, Brian T. Hill, Brad Pohlman, Deepa Jagade...> ;Hematology/Oncology and Stem Cell Therapy. 2020 Dec 5
- A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.Anjali S. Advani, William Tse, Hong Li, Xuefei Jia, Paul Elson, Brenda Cooper, Francis Ali-Osman, Jino Park, Arati V. Rao, David A. Rizzieri, Eunice S. Wang, Claudiu V...> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Dec 3
- Join now to see all
Abstracts/Posters
- Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary EraMatt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat AnalysisMatt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
How the COVID-19 Pandemic Has Affected Cancer Care, ResearchMay 13th, 2020
Cleveland Clinic Appoints Dr. Jame Abraham as Department Chair of Hematology/Medical OncologySeptember 23rd, 2019
Timed PerfectlyJune 1st, 2019- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Cleveland ClinicCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
